Recalls and suspensions

Subscribe to TGA safety information
6 April 2021
Product defect correction - lid magnet may dislodge and cause early battery depletion
23 March 2021
Recall of various medicines containing Artemisia annua and Artemisia absinthium - updated recalled medicines
23 December 2020
Recall due to presence of chloroform
23 December 2020
Recall - potential for split tablets to lead to ineffective dose

More safety information »

Safety information

Subscribe to TGA safety information
21 April 2021
The Therapeutic Goods Administration (TGA) has been closely monitoring suspected side effects (also known as adverse events ) from the use …
16 April 2021
Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine
14 April 2021
The Therapeutic Goods Administration (TGA) has been closely monitoring suspected side effects (also known as adverse events ) from the use …
13 April 2021
Information for consumers and health professionals

More safety information »

News

Subscribe to TGA latest news and updates
21 April 2021
The TGA is pleased to announce the GMP forum 2021, which will be held Wednesday 12 - Friday 14 May 2021 is now open for registration.
21 April 2021
Australian Public Assessment Report for Dapagliflozin
21 April 2021
Australian Public Assessment Report for Guselkumab
20 April 2021
Updated list of applications for new medicines or new uses for existing medicines that are currently under evaluation by the TGA

More news »